In fact, aberrant signaling through the PI3K/AKT pathway, detected as increased AKT phosphorylation, occurs in approximately 70% of cases, and has been associated with poor prognosis, tumor recurrence and resistance to therapy [8,9]. This evidence concerns the gene AKT1 and neoplasm.